NCT06761586View on ClinicalTrials.gov

A Study of AUR104 in Patients with Relapsed/Refractory Lymphoid Malignancies (VIJAY-1)

PHASE1RecruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

December 12, 2024

Primary Completion Date

November 4, 2026

Study Completion Date

January 4, 2027

Conditions
Select Relapsed/Refractory Lymphoid Malignancies
Interventions
DRUG

AUR104

Once or twice a day

Trial Locations (5)

395004

RECRUITING

Kiran Multi Super Speciality Hospital and Research Centre, Surat

395007

RECRUITING

Sunshine Global Hospitals, Surat

395009

RECRUITING

Adwaita Cancer Hospital & ICU, Surat

411004

RECRUITING

MMFHA Joshi Hospital, Pune

416234

RECRUITING

Kolhapur Cancer Centre Pvt. Ltd., Kolhāpur

Sponsors
All Listed Sponsors
lead

Aurigene Discovery Technologies Limited

INDUSTRY